LIGHT MODULATION® / LLLT PATENTED
According to severity of Meibomian glands loss, MGD Mask releases the correct amount of energy and treatment duration for that specific patient.
WHAT ARE THE BENEFITS?
-
COMPLETE + DIRECT TREATMENT
MGD Mask® enables a full therapy, covering both lower and upper eyelids, to grant maximum efficacy in treating Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD), Chalazion, Blepharitis, Sjögren’s Syndrome, Post-blepharoplasty.
-
TOTALLY PAINLESS
MGD Mask® and LM® LLLT provide patients with an entirely painless therapy. Near-infrared light is emitted on the skin at a medically-certified wavelength, generating endogenous heating by stimulating cells’ ATP production.
-
QUICK
For patients, this means immediate relief, just 15’ after the therapy—for operators, it means delivering greater value to patients, with much less effort.
-
EASY
No training needed, no set-up time. It just works.
FIRST APPROVED TREATMENT FOR DRY EYE/MGD USING PHOTOBIOMODULATION
-
PHOTOBIOMODULATION is an innovative technology that solicits mitochondria contained in the cells. Thanks to different wavelengths it is possible to stimulate more specific objectives getting a better energy production within mitochondria.
-
LIGHT MODULATION® triggers biochemical and biophysical reactions that stimulate cells to make a better protein synthesis.
About LM® LLLT
Our patented photobiomodulation technology solicits cells’ mitochondria, triggering biochemical and biophysical reactions that stimulate them to a better protein synthesis. Thanks to the near-infrared emission of light, the tear lipid layer is increased and stabilized. MGD Mask® provides patients with custom treatments based on the MGD severity level detected with me-check® screening. According to the severity of meibomian glands loss, meibomask® releases the correct amount of energy and treatment duration for every specific patient.
